- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Parkinson Disease (PD)
- Meeting Date: July 2021
- Public Summary Document (PSD) July 2021 PBAC Meeting - (PDF 1075KB)
- Public Summary Document (PSD) July 2021 PBAC Meeting - (Word 76KB)
Opicapone – July 2021
Opicapone: Capsule 50 mg; Ongentys®
Last updated
29 October 2021